pd 169316 and dactinomycin

pd 169316 has been researched along with dactinomycin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, A; Hatakeyama, D; Hirade, K; Hotta, K; Ito, H; Kanamori, Y; Katayama, M; Kato, K; Kozawa, O; Matsuno, H; Mori, H; Niwa, M; Uematsu, T1
Agostinis, P; de Witte, P; Hendrickx, N; Moens, U; Piette, J; Seternes, OM; Vandenheede, JR; Volanti, C1
Guo, QL; Song, ZB; Wu, H; Yan, JQ; Yang, Y1
Cao, L; Jiang, X; Tan, R; Xun, J1

Other Studies

4 other study(ies) available for pd 169316 and dactinomycin

ArticleYear
Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils.
    European journal of pharmacology, 2003, Apr-18, Volume: 466, Issue:3

    Topics: Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Heat-Shock Proteins; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neutrophils; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Synthesis Inhibitors; Pyridines; Pyrrolidines; RNA, Messenger; Thiocarbamates; Time Factors; Tumor Necrosis Factor-alpha

2003
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.
    The Journal of biological chemistry, 2003, Dec-26, Volume: 278, Issue:52

    Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; Mutation; NF-kappa B; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Perylene; Photochemotherapy; Precipitin Tests; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Sulfonamides; Time Factors; Transcription, Genetic; Transfection; Up-Regulation

2003
Tumor necrosis factor-α inhibits angiotensin II receptor type 1 expression in dorsal root ganglion neurons via β-catenin signaling.
    Neuroscience, 2013, Sep-17, Volume: 248

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; beta Catenin; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Ganglia, Spinal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Imidazoles; Indoles; Male; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinazolines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha

2013
Propofol up-regulates Mas receptor expression in dorsal root ganglion neurons.
    Die Pharmazie, 2013, Volume: 68, Issue:8

    Topics: Anesthetics, Intravenous; Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Dactinomycin; Ganglia, Spinal; Imidazoles; Indicators and Reagents; Neurons; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Propofol; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; RNA, Messenger

2013